Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Encephalopathies caused by valproate].

R Göbel1, A Görtzen, P Bräunig

  • 1Westfälisches Zentrum für Psychiatrie und Psychotherapie Bochum-Universitätsklinik.

Fortschritte Der Neurologie-Psychiatrie
|March 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A moiré deflectometer for antimatter.

Nature communications·2014
Same author

Intraspinal endometriosis as a possible cause of recurrent back pain and leg monoparesis.

European journal of neurology·2013
Same author

Slowly contracting muscles power the rapid jumping of planthopper insects (Hemiptera, Issidae).

Cell and tissue research·2013
Same author

[Not Available].

Mycotoxin research·2013
Same author

[Not Available].

Mycotoxin research·2013
Same author

[Not Available].

Mycotoxin research·2013

Valproic acid (VPA) can cause encephalopathy, a rare side effect with cognitive and behavioral symptoms. Stopping VPA usually resolves these effects, but treatment roles for L-carnitine and citrulline are uncertain.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Toxicology

Background:

  • Valproic acid (VPA) is widely prescribed for epilepsy and bipolar disorder.
  • VPA-induced encephalopathy is a rare but serious adverse effect.
  • Understanding VPA's neurological impact is crucial for patient safety.

Observation:

  • Two cases of VPA-induced encephalopathy are presented.
  • Symptoms include somnolence, reduced motor activity, and cognitive/behavioral decline.
  • Encephalopathy can occur independently of VPA blood levels.

Findings:

  • Potential mechanisms include hepatic enzyme interactions, direct neurotoxicity, drug interactions, and metabolic disturbances.
  • Withdrawal of VPA typically leads to symptom regression within days.

Related Experiment Videos

  • The efficacy of L-carnitine or citrulline supplementation is not clearly established.

    • Implications:

    • Highlights the importance of recognizing VPA-induced encephalopathy in clinical practice.
    • Suggests further research into the underlying mechanisms of VPA neurotoxicity.
    • Informs treatment strategies and the need for careful patient monitoring during VPA therapy.